Cyclerion Therapeutics Announces Praliciguat Topline Phase 2 Results in Diabetic Nephropathy

NEXT STORY
Cue Biopharma Announces Upcoming Scientific Presentation at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting
PREV STORY
Kura Oncology to Report Third Quarter 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

B.C. pharmacists on the frontline to help in opioid crisis

VANCOUVER, British Columbia, March 07, 2018 (GLOBE NEWSWIRE) -- While 2017 is marked as ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT BIOTECH’S FINANCIAL INFORMATION SCHEDULE AND AGM 2017

FIT Biotech OyCompany announcement, December 19, 2016 at 14:30 am EET                                           FIT BIOTECH'S FINANCIAL ...

author_avatar
NASDAQ Market News

AMAG Pharmaceuticals Announces FDA Acceptance of New Drug Application Filing for Bremelanotide

WALTHAM, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced ...

author_avatar
NASDAQ Market News